The Filing Desk

electroCore vs Orchestra BioMed

electroCore ECOR · Orchestra BioMed OBIO · Health Care Equipment

Orchestra BioMed reported revenue of $34 million in fiscal 2025, about the same as electroCore's $32 million in fiscal 2025. electroCore's revenue grew 27.2% in its latest year, and Orchestra BioMed's grew 1169.2%. electroCore had an operating margin of -41.1%, against -154.7% at Orchestra BioMed. Free cash flow was −$8 million at electroCore and −$49 million at Orchestra BioMed.

Side by side

electroCoreOrchestra BioMed
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$32M$34M
Revenue growth27.2%1,169.2%
Revenue growth a year, last 5 years55.7%—
Gross margin86.8%99.4%
Operating margin−41.1%−154.7%
Net margin−43.6%−157.4%
Free cash flow−$8M−$49M
Free cash flow margin−25.8%−147.7%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count13.4%29.7%
Last close$4.85$7.00
P/E at the last close——
Insider trades, last 12 monthsbought $176,158, sold $933,001bought $259,541, sold $257,682
Piotroski F-score—5 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
electroCoreOrchestra BioMed
Operating margin
Percent of revenue
electroCoreOrchestra BioMed
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
electroCoreOrchestra BioMed

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the electroCore and Orchestra BioMed pages.